ID | 32303 |
JaLCDOI | |
フルテキストURL | |
著者 |
Ogawa, Norio
Okayama University
|
抄録 | Levodopa is the gold standard for the treatment of Parkinson's disease (PD) because of its outstanding clinical efficacy. However, the majority of patients experience various adverse reactions, including the wearing-off phenomenon, the on-off phenomenon, dyskinesia and psychiatric symptoms. The response to levodopa depends not only on the intrinsic responsiveness of the patients, but also on various other important factors including the type of levodopa preparation, its absorption/metabolism, the blood-brain barrier, age at onset of disease and concomitant use of anti-parkinsonian drugs. This review summarizes factors which influence the effects of levodopa in PD. To minimize levodopa-induced adverse reactions and to relieve long-term parkinsonian symptoms, levodopa therapy should be conducted by taking these factors into consideration. |
キーワード | dopamine agonist
monoamine oxidase-B(MAO-B) inhibitor
catechol-O-methyltransferase(COMT)inhibitor
blood-brain barrier
age at onset
large neutral amino acids
gastric acidity
|
Amo Type | Review
|
出版物タイトル |
Acta Medica Okayama
|
発行日 | 2000-06
|
巻 | 54巻
|
号 | 3号
|
出版者 | Okayama University Medical School
|
開始ページ | 95
|
終了ページ | 101
|
ISSN | 0386-300X
|
NCID | AA00508441
|
資料タイプ |
学術雑誌論文
|
言語 |
英語
|
論文のバージョン | publisher
|
査読 |
有り
|
PubMed ID | |
Web of Science KeyUT |